Marshall Wace, LLP Petmed Express Inc Transaction History

Marshall Wace, LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.95 - $4.84 $44,923 - $55,045	11,373 New	11,373 $46,000
Q1 2022 May 16, 2022	SELL	$23.62 - $29.18 $1.09 Million - $1.35 Million	-46,357 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.26 - $32.0 $1.17 Million - $1.48 Million	46,357 New	46,357 $1.17 Million
Q1 2021 May 17, 2021	SELL	$29.77 - $51.8 $1.84 Million - $3.2 Million	-61,767 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$28.96 - $33.77 $1.79 Million - $2.09 Million	61,767 New	61,767 $1.98 Million
Q2 2020 Aug 13, 2020	SELL	$27.94 - $40.96 $188,092 - $275,742	-6,732 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$22.18 - $28.78 $149,315 - $193,746	6,732 New	6,732 $194,000
Q2 2019 Aug 14, 2019	SELL	$15.32 - $23.65 $2.78 Million - $4.3 Million	-181,661 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$20.5 - $24.32 $6.7 Million - $7.94 Million	-326,650 Reduced 64.26%	181,661 $4.14 Million
Q4 2018 Feb 14, 2019	BUY	$22.42 - $32.67 $11.4 Million - $16.6 Million	508,311 New	508,311 $11.8 Million

104

9.65M

39.6K

137K

Ticker PETS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 21,013,800
Market Cap $107M
Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.